To test whether rapamycin’s inhibition of mTOR signaling leads to a decrease in cell growth and in the proliferation of gallbladder carcinoma cells, SGC-996 cells were treated with different concentrations of rapamycin for 24, 48, and 72 h, with cell viability subsequently determined by MTT assay. Here, MTOR is linked to gallbladder carcinoma.